ABL Bio, Inc.

ophthalmic preparations; ophthalmologic preparations; biopharmaceutical preparations for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; biological preparations for medical or veterinary purposes for the treatment and prevention of cancers, neurodegenerative diseases, and infectious diseases; diagnostic reagents for medical or veterinary purposes; biotechnological pharmaceutical preparations for medical purposes for the treatment and prevention of cancers, neurodegenerative diseases, and infectious diseases; biological preparations for medical purposes for the treatment and prevention of cancers, neurodegenerative diseases, and infectious diseases; antibodies being biological preparations for medical purposes for the treatment and prevention of cancers, neurodegenerative diseases, and infectious diseases; pharmaceutical preparations for the treatment of tumors; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical preparations acting on the central nervous system; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations for the treatment of Parkinson's disease; anti-cancer preparations; tumor suppressing agents; immunostimulants; pharmaceutical compositions, namely, pharmaceutical preparations for the treatment and prevention of cancers, neurodegenerative diseases, and infectious diseases | scientific research in the fields of biomedicine; scientific research for medical purposes in the area of cancerous diseases; development of pharmaceutical preparations and medicines; provision of medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of technology for biotechnology; biotechnological research; medical research in the field of medicine; scientific research in the field of medicine; laboratory research services relating to pharmaceuticals; scientific research in the field of medicinal products; research and development of vaccines and medicines; drug discovery services; scientific research for medical purposes in the field of cancerous diseases; pharmaceutical products development; pharmaceutical research and development; research on the subject of pharmaceuticals; medical and scientific research, namely, conducting testing in the nature of clinical trials of medicines for others; medical and scientific research, namely, conducting studies in the nature of clinical trials of medicines for others; development of cell therapy products; scientific research in the field of pharmaceuticals

ophthalmic preparations; ophthalmologic preparations; biopharmaceutical preparations for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; biological preparations for medical or veterinary purposes for the treatment and prevention of cancers, neurodegenerative diseases, and infectious diseases; diagnostic reagents for medical or veterinary purposes; biotechnological pharmaceutical preparations for medical purposes for the treatment and prevention of cancers, neurodegenerative diseases, and infectious diseases; biological preparations for medical purposes for the treatment and prevention of cancers, neurodegenerative diseases, and infectious diseases; antibodies being biological preparations for medical purposes for the treatment and prevention of cancers, neurodegenerative diseases, and infectious diseases; pharmaceutical preparations for the treatment of tumors; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical preparations acting on the central nervous system; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations for the treatment of Parkinson's disease; anti-cancer preparations; tumor suppressing agents